Table 2.
Prevalence of diabetes mellitus and diabetes treatment in the SAMINOR study (N=15 112)
| Sami (N=2559) | Non-Sami (N=4731) | ||
|---|---|---|---|
| Men | n (%) | n (%) | p Value |
| Diabetes prevalence | 132 (5.2) | 212 (4.5) | 0.19* |
| Insulin treatment | 13 (0.5) | 31 (0.7) | |
| Tablet treatment | 45 (1.8) | 87 (1.8) | |
| Insulin and tablet treatment | 25 (1.0) | 21 (0.4) | |
| Non-treatment | 49 (1.9) | 73 (1.5) | |
| Non-diabetes | 2427 (33.3) | 4519 (95.5) | 0.05† |
| Sami (N=2581) | Non-Sami (N=5241) | ||
| Women | n (%) | n (%) | p Value |
| Diabetes prevalence | 129 (5.0) | 220 (4.2) | 0.11* |
| Insulin treatment | 13 (0.5) | 29 (0.6) | |
| Tablet treatment | 61 (2.4) | 71 (1.6) | |
| Insulin and tablet treatment | 20 (0.8) | 38 (0.7) | |
| Non-treatment | 35 (1.4) | 82 (1.6) | |
| Non-diabetes | 2452 (95.0) | 5021 (95.8) | 0.025† |
*χ2 Test for differences in diabetes prevalence among Sami versus non-Sami.
†χ2 Test for differences in treatment level among Sami versus non-Sami.